AI will be banned for therapeutic decision-making, but will still be allowed for administrative and supplementary support.

Blue Shield of California is entering into a partnership with Gemini Health on drug price transparency to promote the lowest ...

Inpatient Psychiatric Facilities (IPFs) will get a 2.5% payment bump under the IPF Prospective Payment System final rule ...

The administration wants drugmakers to bring medication prices more closely in line with the Most-Favored Nation pricing ...

CMS is finalizing its proposal to remove four SDOH standardized patient assessment data elements to reduce burden.

Without giving details of which markets would be affected, UnitedHealthcare CEO Tim Noel said, “Additionally, and ...

UHG says it’s confident in its business practices and has begun complying with formal civil and criminal DOJ requests.

While revenue is up, profit was just $3.4 billion in the quarter, while Optum was $6.6 billion below earnings expectations.

The company updated full-year revenue expectations to at least $128 billion, a $2 billion increase over its prior projection.

An appeals court has ruled against a legal challenge to the Drug Price Negotiation Program. On Wednesday, the U.S. Court of Appeals for the Sixth Circuit sided with the Department of Health and Human ...

Cigna reaffirmed its guidance on Thursday, logging a strong second quarter despite persistently high medical costs that are ...

The Arkansas law would have barred companies that own PBMs from also holding a pharmacy license. It had been set to take ...